Transplant Genomics, Inc.
Clinical trials sponsored by Transplant Genomics, Inc., explained in plain language.
-
Blood test may replace biopsies for kidney transplant patients
Knowledge-focused Not yet recruitingThis study watches 600 kidney transplant patients to see if a blood test (TruGraf and TRAC) can spot early signs of rejection or kidney problems. It aims to reduce the need for invasive biopsies and improve long-term care. Participants will be followed for 24 months after their t…
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
New blood test aims to stop viruses after kidney transplants
Knowledge-focused Not yet recruitingThis study will follow 1000 kidney transplant patients for 12 months to see if a new blood test called T-ID can predict and prevent two serious viral infections: CMV disease and BK virus kidney damage. The test measures virus levels and the body's immune strength. The goal is to …
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC